Activity of TAK1 stimulates the downstream signaling mediators and transcription factors, such as JNK, p38 MAPK, and NFκB. Consistent with TAK1 activation, phosphorylation of JNK was upregulated in patients with IBD; more prominently in patients with CD (Fig. 1). This evidence concerns the gene NFKB1 and inflammatory bowel disease.